Genmab — December 2017

[E_L]

tweet on AL amyloidosis https://twitter.com/BursatilBiotech/status/943903615126851586

[E_L]

Highlights from ASH 2017: Research Update on AL amyloidosis http://www.arci.org/blog-1/2017/12/14/highlights-from-ash-2017-research-update

[E_L]

video - Major breakthroughs in AL amyloidosis treatment from ASH 2017 - https://www.vjhemonc.com/video/fpeohrztdaq-major-breakthroughs-in-al-amyloidosis-treatment-from-ash-2017/

[bibob]

Thanks E L. Again we see that Dara is a unik drug. So,- go on, use it.

[Helge_LarsenPI-redaktør]

Et lille sidespring. Hermed min analyse fra i dag på Nuevolution lægemiddeludviklingsmaskine. http://www.proinvestor.com/aktieanalyser/255/

[E_L]

Helge giving us some Xmas reading; he is worried we will be bored!

[JKY_VH]

Tak E L

[E_L]

Did we see this before? :

[E_L]

Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma. - https://www.ncbi.nlm.nih.gov/pubmed/29260507

[E_L]

i mean , it is a small study, but ORR = 100%

[E_L]

One hundred percent.

[E_L]

all of them.

[nohope]

Helge´s Christmas Fairy Tales are great ! I fell asleep halfway through. Will spare other half for next time I can´t sleep.

[pauly]

very impresive EL

[Thestrup7]

Har https://finance.yahoo.com/news/brief-janssen-enters-collaboration-license-223259225.html

[Thestrup7]

Nogen betydning for Genmab?

[Sukkeralf]

Endnu en bekræftigelse på at CAR-T BCMA skal tages alvorligt - dog bedre at Janssen får kontrol med Legens behandling og ikke en anden stor konkurrent. Så må vi se hen ad vejen om der bliver kombineret med Daratumumab på en eller anden måde

[Sukkeralf]

Legends behandling fyldte ikke meget på ASH, men

[Sukkeralf]

Assessing the BCMA scene

Differences in patient populations and a dearth of clinical outcome data mean it’s too soon to declare bluebird bio Inc.’s anti-BCMA chimeric...

BioCentury (www.biocentury.com)

[bibob]

God morgen.